Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.


Articles from the journal Current Molecular Medicine, Volume 16 Issue 4:

  • HOX Genes as Potential Markers of Circulating Tumour Cells
  • Prostacyclin, Atherothrombosis and Diabetes Mellitus: Physiologic and Clinical Considerations
  • The Impact of CRISPR/Cas9-Based Genomic Engineering on Biomedical Research and Medicine
  • The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
  • VEGF Promotes Glycolysis in Pancreatic Cancer via HIF1α Up-Regulation
  • MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer
  • STAT3 Activation in Circulating Monocytes Contributes to Neovascular Age-Related Macular Degeneration
  • Higher Expression of NOD1 and NOD2 is Associated with Vogt-Koyanagi-Harada (VKH) Syndrome But Not Behcet’s Disease (BD)

For details on the articles, please visit this link ::